Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission – a UK case study

Key Points

• The aim is to improve economic modeling for assessing obesity treatments, incorporating diabetes progression and sleep apnea.
• Developed an enhanced economic model for obesity pharmacotherapy.
• Focused on integration of type 2 diabetes progression and obstructive sleep apnea remission.
• Designed to support evidence-based decision-making for chronic weight management.
• The model increases clinical relevance and usability for obesity treatment evaluations.
• Provides a scalable platform for future therapeutic assessments.